Debt-to-equity of vTv Therapeutics Inc. from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
vTv Therapeutics Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • vTv Therapeutics Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 107%, a 73% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

vTv Therapeutics Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 107% -288% -73% 30 Sep 2025
Q2 2025 254% +1150% 30 Jun 2025
Q1 2025 191% +404% 31 Mar 2025
Q4 2024 160% +284% 31 Dec 2024
Q3 2024 395% +537% 30 Sep 2024
Q2 2024 -896% -739% -471% 30 Jun 2024
Q1 2024 -213% -7% -3.6% 31 Mar 2024
Q4 2023 -123% +102% +45% 31 Dec 2023
Q3 2023 -142% +48% +25% 30 Sep 2023
Q2 2023 -157% -27% -21% 30 Jun 2023
Q1 2023 -206% -158% -329% 31 Mar 2023
Q4 2022 -225% -197% -695% 31 Dec 2022
Q3 2022 -190% -171% -902% 30 Sep 2022
Q2 2022 -130% -111% -602% 30 Jun 2022
Q1 2022 -48% -28% -142% 31 Mar 2022
Q4 2021 -28% -6% -29% 31 Dec 2021
Q3 2021 -19% +9% +32% 30 Sep 2021
Q2 2021 -18% +13% +41% 30 Jun 2021
Q1 2021 -20% +17% +46% 31 Mar 2021
Q4 2020 -22% +19% +46% 31 Dec 2020
Q3 2020 -28% +11% +29% 30 Sep 2020
Q2 2020 -31% +15% +33% 30 Jun 2020
Q1 2020 -37% +15% +28% 31 Mar 2020
Q4 2019 -40% +3% +6.8% 31 Dec 2019
Q3 2019 -39% +2% +3.7% 30 Sep 2019
Q2 2019 -47% -14% -45% 30 Jun 2019
Q1 2019 -51% -23% -84% 31 Mar 2019
Q4 2018 -43% -17% -63% 31 Dec 2018
Q3 2018 -41% -16% -65% 30 Sep 2018
Q2 2018 -32% -11% -48% 30 Jun 2018
Q1 2018 -28% -9% -52% 31 Mar 2018
Q4 2017 -27% -11% -74% 31 Dec 2017
Q3 2017 -25% -13% -117% 30 Sep 2017
Q2 2017 -22% -11% -107% 30 Jun 2017
Q1 2017 -18% 31 Mar 2017
Q4 2016 -15% 31 Dec 2016
Q3 2016 -11% 30 Sep 2016
Q2 2016 -11% 30 Jun 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.